102 related articles for article (PubMed ID: 17259148)
21. Mouse model of respiratory syncytial virus infection to evaluate antiviral activity in vivo.
Sudo K; Watanabe W; Mori S; Konno K; Shigeta S; Yokota T
Antivir Chem Chemother; 1999 May; 10(3):135-9. PubMed ID: 10431613
[TBL] [Abstract][Full Text] [Related]
22. Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.
Elliott MB; Chen T; Terio NB; Chong SY; Abdullah R; Luckay A; Egan MA; Boutilier LA; Melville K; Lerch RA; Long D; Eldridge JH; Parks CL; Udem SA; Hancock GE
Vaccine; 2007 Oct; 25(41):7132-44. PubMed ID: 17850933
[TBL] [Abstract][Full Text] [Related]
23. Host transcription profiles upon primary respiratory syncytial virus infection.
Janssen R; Pennings J; Hodemaekers H; Buisman A; van Oosten M; de Rond L; Oztürk K; Dormans J; Kimman T; Hoebee B
J Virol; 2007 Jun; 81(11):5958-67. PubMed ID: 17376894
[TBL] [Abstract][Full Text] [Related]
24. Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice.
Dakhama A; Lee YM; Ohnishi H; Jing X; Balhorn A; Takeda K; Gelfand EW
J Allergy Clin Immunol; 2009 Jan; 123(1):138-145.e5. PubMed ID: 19056111
[TBL] [Abstract][Full Text] [Related]
25. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
[TBL] [Abstract][Full Text] [Related]
26. Antiviral effects of Jinxin oral liquid against respiratory syncytial virus infection in the BALB/c mice model.
Chen ZG; Luo H; Wang SC; Xu JY; Li JX
J Ethnopharmacol; 2015 Mar; 162():287-95. PubMed ID: 25593018
[TBL] [Abstract][Full Text] [Related]
27. RNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune response.
Zhang W; Tripp RA
J Virol; 2008 Dec; 82(24):12221-31. PubMed ID: 18818323
[TBL] [Abstract][Full Text] [Related]
28. Treatment of respiratory syncytial virus pneumonia in a lung transplant recipient: case report and review of the literature.
Flynn JD; Akers WS; Jones M; Stevkovic N; Waid T; Mullett T; Jahania S
Pharmacotherapy; 2004 Jul; 24(7):932-8. PubMed ID: 15303457
[TBL] [Abstract][Full Text] [Related]
29. [Study on the inhibitory effect of Reduqing Oral Liquid on respiratory syncytial virus in vitro].
Huang SH; Feng XL; Liu W
Zhong Yao Cai; 2009 Apr; 32(4):579-81. PubMed ID: 19645247
[TBL] [Abstract][Full Text] [Related]
30. A novel inhibitor of respiratory syncytial virus isolated from ethnobotanicals.
Ojwang JO; Wang YH; Wyde PR; Fischer NH; Schuehly W; Appleman JR; Hinds S; Shimasaki CD
Antiviral Res; 2005 Dec; 68(3):163-72. PubMed ID: 16280176
[TBL] [Abstract][Full Text] [Related]
31. [Effect of baicalin on in vivo anti-virus].
Chu ZY; Chu M; Teng Y
Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(22):2413-5. PubMed ID: 18257272
[TBL] [Abstract][Full Text] [Related]
32. IL-9 regulates pathology during primary and memory responses to respiratory syncytial virus infection.
Dodd JS; Lum E; Goulding J; Muir R; Van Snick J; Openshaw PJ
J Immunol; 2009 Dec; 183(11):7006-13. PubMed ID: 19915054
[TBL] [Abstract][Full Text] [Related]
33. [The anti-respiratory syncytial virus effect of an active compound (AP3) from a Chinese medicinal herb-Herba patriniae in vitro].
Li SS; Li HY; Piao YA; Liu DL; Tian WJ; Dong YM
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Feb; 25(2):150-3. PubMed ID: 15132871
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of RD3-0028 aerosol treatment against respiratory syncytial virus infection in immunosuppressed mice.
Sudo K; Watanabe W; Konno K; Sato R; Kajiyashiki T; Shigeta S; Yokota T
Antimicrob Agents Chemother; 1999 Apr; 43(4):752-7. PubMed ID: 10103176
[TBL] [Abstract][Full Text] [Related]
35. Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV.
Skaricic D; Traube C; De B; Joh J; Boyer J; Crystal RG; Worgall S
Virology; 2008 Aug; 378(1):79-85. PubMed ID: 18556039
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of respiratory viruses by nasally administered siRNA.
Bitko V; Musiyenko A; Shulyayeva O; Barik S
Nat Med; 2005 Jan; 11(1):50-5. PubMed ID: 15619632
[TBL] [Abstract][Full Text] [Related]
37. C57Bl/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccine.
Cyr SL; Jones T; Stoica-Popescu I; Burt D; Ward BJ
Vaccine; 2007 Apr; 25(16):3228-32. PubMed ID: 17374422
[TBL] [Abstract][Full Text] [Related]
38. Respiratory syncytial virus protects against the subsequent development of Japanese cedar pollen-induced allergic responses.
Liu B; Kimura Y
J Med Virol; 2007 Oct; 79(10):1600-5. PubMed ID: 17705182
[TBL] [Abstract][Full Text] [Related]
39. Lack of long-term effects of respiratory syncytial virus infection on airway function in mice.
Collins RA; Gualano RC; Zosky GR; Chiappetta CL; Turner DJ; Colasurdo GN; Hantos Z; Sly PD
Respir Physiol Neurobiol; 2007 Jun; 156(3):345-52. PubMed ID: 17236822
[TBL] [Abstract][Full Text] [Related]
40. [Inhibition of respiratory syncytial virus (RSV) by moroxydine, allicin, alpha-interferon and their joint application].
Zhou G; Han S; Shi Y; Sui H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):286-9. PubMed ID: 15617350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
